Phagocytic glioblastoma-associated microglia and macrophages populate invading pseudopalisades.

Brain Commun

Neuroimmunity Research Group, Department of Biochemistry and Molecular Biology, School of Medicine, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès, Barcelona 08193, Spain.

Published: December 2019

Hypoxic pseudopalisades are a pathological hallmark of human glioblastoma, which is linked to tumour malignancy and aggressiveness. Yet, their function and role in the tumour development have scarcely been explored. It is thought that pseudopalisades are formed by malignant cells escaping from the hypoxic environment, although evidence of the immune component of pseudopalisades has been elusive. In the present work, we analyse the immunological constituent of hypoxic pseudopalisades using high-resolution three-dimensional confocal imaging in tissue blocks from excised tumours of glioblastoma patients and mimic the hypoxic gradient in microfluidic platforms to understand the cellular motility. We visualize that glioblastoma-associated microglia and macrophages abundantly populate pseudopalisades, displaying an elongated kinetic morphology across the pseudopalisades, and are oriented towards the necrotic focus. experiments demonstrate that under hypoxic gradient, microglia show a particular motile behaviour characterized by the increase of cellular persistence in contrast with glioma cells. Importantly, we show that glioblastoma-associated microglia and macrophages utilize fibres of glioma cells as a haptotactic cue to navigate along the anisotropic structure of the pseudopalisades and display a high phagocytic activity at the necrotic border of the pseudopalisades. In this study, we demonstrate that glioblastoma-associated microglia and macrophages are the main immune cells of pseudopalisades in glioblastoma, travelling to necrotic areas to clear the resulting components of the prothrombotic milieu, suggesting that the scavenging features of glioblastoma-associated microglia and macrophages at the pseudopalisades serve as an essential counterpart for glioma cell invasion.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491442PMC
http://dx.doi.org/10.1093/braincomms/fcz043DOI Listing

Publication Analysis

Top Keywords

glioblastoma-associated microglia
20
microglia macrophages
20
pseudopalisades
11
hypoxic pseudopalisades
8
hypoxic gradient
8
glioma cells
8
microglia
6
macrophages
5
hypoxic
5
phagocytic glioblastoma-associated
4

Similar Publications

Microglia membrane-mediated trans-blood-brain barrier prodrug micelles enhance phagocytosis for glioblastoma chemo-immunotherapy.

J Control Release

January 2025

College of Pharmaceutical Science, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China. Electronic address:

Glioblastoma-associated macrophages & microglia (GAMs) are critical immune cells within the glioblastoma (GBM) microenvironment. Their phagocytosis of GBM cells is crucial for initiating both innate and adaptive immune responses. GBM cells evade this immune attack by upregulating the anti-phagocytic molecule CD47 on their surface.

View Article and Find Full Text PDF

A recent study outlines the phenotypes of brain border region macrophages in developing, normal and glioblastoma-affected brains. For the first time, the authors show in-vivo turnover of human brain border macrophages. The findings have implications for the understanding of brain border immunity and potential macrophage targeting therapies.

View Article and Find Full Text PDF
Article Synopsis
  • The human central nervous system (CNS) has a diverse immune compartment that includes various cell populations, notably microglia (brain macrophages) and CNS-associated macrophages (CAMs), which are less common and not well studied.
  • Researchers used advanced techniques like single-cell RNA sequencing and spatial transcriptomics to analyze over 356,000 transcriptomes from 102 individuals, revealing insights into the presence and variability of CAM subclasses in different conditions.
  • The study also examined myeloid cell types in glioblastoma samples, finding that the immune responses to hypoxia differ significantly between cancer-affected areas and healthy brain regions, emphasizing the complexity of the brain's immune system.
View Article and Find Full Text PDF
Article Synopsis
  • MRI with gadolinium (Gd) is commonly used to monitor glioblastoma treatment but lacks specificity in revealing the tumor's immune environment; ferumoxytol (Fe), an iron nanoparticle, targets macrophages and microglia within glioblastomas.
  • In a study involving stereotactic biopsy samples and RNA microarray analysis, researchers examined how different MRI contrast agents (Gd versus Fe) correlated with immune pathways and gene expression patterns in glioblastoma patients.
  • Findings indicated that Fe-enhanced imaging provided a better understanding of immune processes, showing higher levels of immune-related gene sets and M2 polarized macrophages, highlighting its potential to inform treatment and tumor biology more effectively than standard Gd-based imaging.
View Article and Find Full Text PDF
Article Synopsis
  • - Targeting glioblastoma-associated macrophages and microglial cells (GAMs) can significantly enhance patient outcomes, particularly through the inhibition of the colony-stimulating factor-1 receptor (CSF1R).
  • - In experiments, three CSF1R-targeting drugs were tested on patient-derived GAMs, with GW2580 proving the most effective in reprogramming them to enhance anti-tumor immune responses and decrease tumor proliferation.
  • - GW2580 showed notable promise by promoting a pro-inflammatory GAM phenotype and supporting antitumor T-cell responses, indicating its potential as a key treatment in future glioblastoma therapies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!